CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash flows from operating activities:
Net income	$ 11,457	$ 12,705	$ 10,172
Gain (loss) from discontinued operations (Note 3)	0	392	(141)
Income from continuing operations	11,457	12,313	10,313
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	3,823	3,564	2,987
Amortization of intangible assets	3,792	1,541	3,305
Share-based compensation	686	718	736
Investment income from equity interest	(123)	(228)	(355)
Tax benefit from stock plan transactions, net of tax deficiencies from equity awards	(590)	(143)	127
Litigation payment	0	0	(15,000)
Loss on extinguishment of debt	193	0	0
Settlement of derivative instrument	340	0	0
Deferred income taxes	4,857	(183)	9,362
Other	404	(507)	(637)
Change in operating assets and liabilities:
Contract receivables, net	3,750	24,175	(1,937)
Prepaid expenses and other current assets	1,924	2,778	(3,996)
Accounts payable	1,019	1,151	(2,342)
Accrued compensation and employee benefits	109	1,689	2,713
Other accrued expenses	227	831	(2,043)
Other long-term liabilities	(5,896)	(6,368)	4,975
Net cash provided by continuing operations	25,972	41,331	8,208
Net cash used in discontinued operations	0	(161)	(280)
Net cash provided by operating activities	25,972	41,170	7,928
Cash flows from investing activities:
Purchase of business, net of cash acquired	(142,883)	0	(4,250)
Additions to property and equipment	(1,714)	(4,449)	(5,185)
Proceeds from the sale of business	0	1,750	0
Proceeds from sale of investments and long-lived assets	18	20	215
Dividends from equity investment	84	207	556
Change in other assets	80	385	(345)
Net cash used in continuing operations	(144,415)	(2,087)	(9,009)
Net cash used in discontinued operations	0	(75)	(71)
Net cash used in investing activities	(144,415)	(2,162)	(9,080)
Cash flow from financing activities:
Borrowings under loan agreements	144,021	0	0
Repayments under previous term loan	(22,000)	(8,000)	(8,000)
Repayments under new term loan	(30,000)	0	0
Borrowings under revolving credit agreement	18,478	34,156	79,497
Repayments under revolving credit agreement	(18,478)	(36,129)	(77,524)
Payments of deferred financing cost	(1,943)	0	0
Proceeds from the exercise of stock plan transactions	1,831	1,480	250
Payments of repurchased shares	(311)	(550)	0
Tax benefit from stock plan transactions, net of tax deficiencies from equity awards	590	143	(127)
Net cash provided by (used in) financing activities	92,188	(8,900)	(5,904)
Net increase (decrease) in cash and cash equivalents	26,255	(30,108)	7,056
Cash and cash equivalents, beginning of period	30,163	55	7,111
Cash and cash equivalents, end of period	3,908	30,163	55
Supplemental disclosure of cash flow information:
Cash paid during the year for interest	4,336	936	2,350
Cash paid during the year for income taxes, net of refunds	2,503	6,207	522
Supplemental disclosure of noncash financing and investing activities:
Increase (decrease) in pension accumulated other comprehensive loss	9,982	2,066	(2,630)
Accrual of additions to property and equipment	2,910	0	2,767
Accrual of net working capital payment on purchase of business	2,388	0	0
Issuance of restricted stock	710	333	903
Increase (decrease) in fair value of derivative liability	(473)	(102)	(291)
Note receivable from sale of business	$ 0	$ 750	$ 0